Complete tissue sectioning: Combined processing technique for dermatologic studies requiring confirmation of disease clearance - 17/04/26
Doi : 10.1016/j.jaad.2026.01.042
Marie Clark, MD a, Jalal Maghfour, MD a, Ben J. Friedman, MD a, Jennifer Healy, BA, HT (ASCP) a, Molly Powers, MD a, David Ozog, MD a, b, ⁎ 
a Department of Dermatology, Henry Ford Health, Detroit, Michigan
b Department of Dermatology, Department of Medicine, Michigan State University, East Lansing, Michigan
∗ Correspondence to: David Ozog, MD, Department of Dermatology, Henry Ford Medical Center-New Center One, 3031 W. Grand Blvd, Suite 800, Detroit, MI 48202 Department of Dermatology Henry Ford Medical Center-New Center One 3031 W. Grand Blvd, Suite 800 Detroit MI 48202
Key words : clinical trials, dermatology, Mohs surgery, peripheral and deep en face margin assessment
Plan
| Funding sources: None. |
|
| Patient consent: Not applicable. |
|
| IRB approval status: Not applicable. |
© 2026
American Academy of Dermatology, Inc.. Publié par Elsevier Masson SAS. Tous droits réservés.
Vol 94 - N° 5
P. 1563-1565 - mai 2026 Retour au numéro
Article précédent
- Pentoxifylline and long-term risk of keloid formation: A real-world 10-year outcomes study using TriNetX
- Robert Adler, Michael Kozlov, Fariha Ahmed, Kathryn Liston, Manan D. Mehta, Emily Cowen, Katerina Svigos, Eve J. Lowenstein
- Recognizing the shift toward prepectoral breast implants: Implications for dermatologic surgery
- Megan Trager, Emily Gale, Karen Connolly, Joseph Disa, Kishwer Nehal
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?